OQROStart free trial
Politician trade (House)

Medtronic (MDT): Rep. Emily Randall (WA06) disclosed a sale $1K–$15K

Rep. Emily Randall (WA06) disclosed a sale of Medtronic in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
36 days
Disclosure lag
Traded
Jan 6, 2025
Disclosed
Feb 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 6, 2025 · this disclosureCongressDisclosed sale of MDT — reported range $1,001 - $15,000

What came next

  1. Jan 8, 2025Insider · 1 personInsiders: 2 sales (~$792K)
  2. Jan 24, 2025InsiderOfficer sold ~$1.12M of MDT shares in the open market
  3. Jan 31, 2025FDARecall: MiniMed insulin pump, REF: 770G (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)
  4. Jan 31, 2025FDARecall: MiniMed insulin pump, REF: 630G (MMT-1714, MMT-1715, MMT-1754, MMT-1755)
  5. Jan 31, 2025FDARecall: MiniMed insulin pump, REF: 720G (MMT-1809, MMT-1810, MMT-1859, MMT-1860, MMT-1867)
  6. Jan 31, 2025FDARecall: Paradigm REF: MMT-712 and MMT-715
  7. Feb 5, 2025FDARecall: Aortic Root Cannula: 1. DLP Aortic Root Cannula A. CANNULA 11012 AR FLOWGUARD 12GA, model no 11012 B. CANNULA 11014 AR FLOWGUARD 14GA, model no. 11014 2. MiAR…
  8. Feb 25, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  9. Feb 26, 2025FDARecall: Shiley Adult Flexible Tracheostomy Tube with TaperGuard Cuff Reusable Inner Cannula, REF: 7CN80R
  10. Mar 4, 2025FDARecall: InPen smart insulin pen, REF: MMT-105NNBLNA, MMT-105NNGYNA, MMT-105NNPKNA, MMT-105ELBLNA, MMT-105ELGYNA, MMT105ELPKNA
  11. Mar 4, 2025FDARecall: Stimulation RC Clinician Programmer Application, Model A71400, when used with the Inceptiv (Model 977119) and Intellis Pro (Model 977118) neurostimulators
  12. Mar 4, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  13. Mar 10, 2025FDAFDA device clearance: Duet External Drainage and Monitoring System (EDMS)
  14. Mar 10, 2025FDARecall: NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM 4.0, REF: NIM4CM01; CONSOLE NIM4CM01RF NIM 4.0 REFURBISHED, REF: NIM4CM01RF; PATIENT INTERFACE NIM4CPB1…
  15. Mar 20, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  16. Mar 24, 2025CongressDisclosed sale of MDT — reported range $50,001 - $100,000
  17. Mar 27, 2025FDAFDA device clearance: SelectSite C304 Deflectable Catheter System (C304); C315 Delivery System (C315)
  18. Apr 3, 2025FDARecall: Enhanced Verify Evaluation Handset (CFN HH90130FA)
  19. Apr 8, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  20. Apr 22, 2025FDAFDA device clearance: Adaptix™ Interbody System with Titan nanoLOCK™ Surface Technology
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 40 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by Rep. Emily Randall (WA06)

The full history of Rep. Emily Randall (WA06) is on the profile page.

How this filing works

Explore the data

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data